Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product

Department of Medicine, New York Hospital-Cornell Medical Center, New York 10021.

OBJECTIVES. The object of this study was to assess the hypothesis that the product of QRS voltage and duration, as an approximation of the time-voltage integral of the QRS complex, can improve the electrocardiographic (ECG) identification of left ventricular hypertrophy. BACKGROUND. Electrocardiographic identification of left ventricular hypertrophy has been limited by the poor sensitivity of standard voltage criteria. However, increases in left ventricular mass can be more closely related to increases in the time-voltage integral of the summed left ventricular dipole than to changes in voltage or QRS duration alone. METHODS. Antemortem ECGs were compared with left ventricular mass at autopsy in 220 patients. There were 95 patients with left ventricular hypertrophy, defined by left ventricular mass index > 118 g/m2 in men and > 104 g/m2 in women. The voltage-duration product was calculated as the product of QRS duration and Cornell voltage (Cornell product) and the 12-lead sum of QRS voltage (12-lead product). RESULTS. At partitions with a matched specificity of 95%, each voltage-duration product significantly improved sensitivity for the detection of left ventricular hypertrophy when compared with simple voltage criteria alone (Cornell product 51% [48 of 95] vs. Cornell voltage 36% [34 of 95], p < 0.005 and 12-lead product 45% [43 of 95] vs. 12-lead voltage 31% [30 of 95], p < 0.001). Sensitivity of both the Cornell product and 12-lead product was significantly greater than that found for QRS duration alone (28%, 27 of 95, p < 0.005) and the Romhilt-Estes point score (27%, 26 of 95, p < 0.005), and compared favorably with the sensitivity of the complex Cornell multivariate score (44%, 42 of 95, p = NS). Comparison of receiver operating characteristic curves demonstrated that improved performance of the voltage-duration products for the detection of left ventricular hypertrophy was independent of test partition selection. In addition, test performance of the voltage-duration products was not significantly affected by the presence or absence of a bundle branch block. CONCLUSIONS. These data suggest that the simple product of either Cornell or 12-lead voltage and QRS duration can identify left ventricular hypertrophy more accurately than can voltage or QRS duration criteria alone and may approach or exceed the performance of more complex multiple regression analyses.

This article has been cited by other articles:

				P. M. Okin, R. B. Devereux, K. E. Harris, S. Jern, S. E. Kjeldsen, L. H. Lindholm, B. Dahlof, and for the LIFE Study Investigators In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study Hypertension, November 1, 2007; 50(5): 984 - 990. [Abstract] [Full Text] [PDF]

				D. Pewsner, P. Juni, M. Egger, M. Battaglia, J. Sundstrom, and L. M Bachmann Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review BMJ, October 6, 2007; 335(7622): 711 - 711. [Abstract] [Full Text] [PDF]

				P. M. Okin, R. B. Devereux, K. E. Harris, S. Jern, S. E. Kjeldsen, S. Julius, J. M. Edelman, B. Dahlof, and for the LIFE Study Investigators Regression of Electrocardiographic Left Ventricular Hypertrophy Is Associated with Less Hospitalization for Heart Failure in Hypertensive Patients Ann Intern Med, September 4, 2007; 147(5): 311 - 319. [Abstract] [Full Text] [PDF]

				K. Wachtell, P. M. Okin, M. H. Olsen, B. Dahlof, R. B. Devereux, H. Ibsen, S. E. Kjeldsen, L. H. Lindholm, M. S. Nieminen, and K. Thygesen Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Therapy and Reduction in Sudden Cardiac Death: The LIFE Study Circulation, August 14, 2007; 116(7): 700 - 705. [Abstract] [Full Text] [PDF]

				J. S. Pankow, D. K. Kwan, B. B. Duncan, M. I. Schmidt, D. J. Couper, S. Golden, and C. M. Ballantyne Cardiometabolic Risk in Impaired Fasting Glucose and Impaired Glucose Tolerance: The Atherosclerosis Risk in Communities Study Diabetes Care, February 1, 2007; 30(2): 325 - 331. [Abstract] [Full Text] [PDF]

				V. Barrios, C. Escobar, A. Calderon, J. Pablo Tomas, S. Ruiz, J. L. Moya, A. Megias, O. Vegazo, and R. Fernandez Regression of left ventricular hypertrophy by a candesartan-based regimen in clinical practice The VIPE study Journal of Renin-Angiotensin-Aldosterone System, December 1, 2006; 7(4): 236 - 242. [Abstract] [PDF]

				P. M. Okin, K. Wachtell, R. B. Devereux, K. E. Harris, S. Jern, S. E. Kjeldsen, S. Julius, L. H. Lindholm, M. S. Nieminen, J. M. Edelman, et al. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. JAMA, September 13, 2006; 296(10): 1242 - 1248. [Abstract] [Full Text] [PDF]

				P. M. Okin, R. B. Devereux, E. Gerdts, S. M. Snapinn, K. E. Harris, S. Jern, S. E. Kjeldsen, S. Julius, J. M. Edelman, L. H. Lindholm, et al. Impact of Diabetes Mellitus on Regression of Electrocardiographic Left Ventricular Hypertrophy and the Prediction of Outcome During Antihypertensive Therapy: The Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study Circulation, March 28, 2006; 113(12): 1588 - 1596. [Abstract] [Full Text] [PDF]

				G. Salles, S. Leocadio, K. Bloch, A. R. Nogueira, and E. Muxfeldt Combined QT Interval and Voltage Criteria Improve Left Ventricular Hypertrophy Detection in Resistant Hypertension Hypertension, November 1, 2005; 46(5): 1207 - 1212. [Abstract] [Full Text] [PDF]

				E. Biagini, A. Elhendy, A. F.L. Schinkel, S. Nelwan, V. Rizzello, R. T. van Domburg, C. Rapezzi, G. Rocchi, M. L. Simoons, J. J. Bax, et al. Prognostic Significance of Left Anterior Hemiblock in Patients With Suspected Coronary Artery Disease J. Am. Coll. Cardiol., September 6, 2005; 46(5): 858 - 863. [Abstract] [Full Text] [PDF]

				P. M. Okin, R. B. Devereux, S. Jern, S. E. Kjeldsen, S. Julius, M. S. Nieminen, S. Snapinn, K. E. Harris, P. Aurup, J. M. Edelman, et al. Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Treatment and the Prediction of Major Cardiovascular Events JAMA, November 17, 2004; 292(19): 2343 - 2349. [Abstract] [Full Text] [PDF]

				K. Alfakih, K. Walters, T. Jones, J. Ridgway, A. S. Hall, and M. Sivananthan New Gender-Specific Partition Values for ECG Criteria of Left Ventricular Hypertrophy: Recalibration Against Cardiac MRI Hypertension, August 1, 2004; 44(2): 175 - 179. [Abstract] [Full Text] [PDF]

				M. P. Schneider, A. U. Klingbeil, C. Delles, M. Ludwig, R. E. Kolloch, M. Krekler, K. O. Stumpe, and R. E. Schmieder Effect of Irbesartan Versus Atenolol on Left Ventricular Mass and Voltage: Results of the CardioVascular Irbesartan Project Hypertension, July 1, 2004; 44(1): 61 - 66. [Abstract] [Full Text] [PDF]

				G. B. J. Mancini, B. Dahlof, and J. Diez Surrogate Markers for Cardiovascular Disease: Structural Markers Circulation, June 29, 2004; 109(25_suppl_1): IV-22 - IV-30. [Full Text] [PDF]

				J. A. Staessen, E. Den Hond, H. Celis, R. Fagard, L. Keary, G. Vandenhoven, and E. T. O'Brien Antihypertensive Treatment Based on Blood Pressure Measurement at Home or in the Physician's Office: A Randomized Controlled Trial JAMA, February 25, 2004; 291(8): 955 - 964. [Abstract] [Full Text] [PDF]

				A. Ciardullo, L Azzolini, M Bevini, T Cadioli, M. Daghio, P Guidetti, M Lorenzetti, P Malavasi, A Morellini, and C Carapezzi A diagnosis of left ventricular hypertrophy on ECG is associated with a high cardiovascular risk: findings from a 40- to 69-year-old cohort in general practice Fam. Pract., February 1, 2004; 21(1): 63 - 65. [Abstract] [Full Text] [PDF]

				E.C. Vourvouri, D. Poldermans, A.F.L. Schinkel, L.Y. Koroleva, F.B. Sozzi, G.E. Parharidis, J.J. Bax, and J.R.T.C. Roelandt Left ventricular hypertrophy screening using a hand-held ultrasound device Eur. Heart J., October 1, 2002; 23(19): 1516 - 1521. [Abstract] [Full Text] [PDF]

				P. M. Okin, R. B. Devereux, M. S. Nieminen, S. Jern, L. Oikarinen, M. Viitasalo, L. Toivonen, S. E. Kjeldsen, S. Julius, B. Dahlof, et al. Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study J. Am. Coll. Cardiol., August 1, 2001; 38(2): 514 - 520. [Abstract] [Full Text] [PDF]

				A. W. Tsai, A. R. Folsom, W. D. Rosamond, and D. W. Jones Ankle-Brachial Index and 7-Year Ischemic Stroke Incidence: The ARIC Study Stroke, August 1, 2001; 32(8): 1721 - 1724. [Abstract] [Full Text] [PDF]

				P. M. Okin, R. B. Devereux, S. Jern, S. E. Kjeldsen, S. Julius, and B. Dahlof Baseline Characteristics in Relation to Electrocardiographic Left Ventricular Hypertrophy in Hypertensive Patients : The Losartan Intervention For Endpoint Reduction (LIFE) in Hypertension Study Hypertension, November 1, 2000; 36(5): 766 - 773. [Abstract] [Full Text] [PDF]

				C. Jaggy, F. Perret, P. Bovet, G. van Melle, N. Zerkiebel, G. Madeleine, L. Kappenberger, and F. Paccaud Performance of Classic Electrocardiographic Criteria for Left Ventricular Hypertrophy in an African Population Hypertension, July 1, 2000; 36(1): 54 - 61. [Abstract] [Full Text] [PDF]

				K. Wachtell, J. N. Bella, P. R. Liebson, E. Gerdts, B. Dahlof, T. Aalto, M. J. Roman, V. Papademetriou, H. Ibsen, J. Rokkedal, et al. Impact of Different Partition Values on Prevalences of Left Ventricular Hypertrophy and Concentric Geometry in a Large Hypertensive Population : The LIFE Study Hypertension, January 1, 2000; 35(1): 6 - 12. [Abstract] [Full Text] [PDF]

				P. M. Okin, S. Jern, R. B. Devereux, S. E. Kjeldsen, B. Dahlof, and f. t. L. S. Group Effect of Obesity on Electrocardiographic Left Ventricular Hypertrophy in Hypertensive Patients : The Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study Hypertension, January 1, 2000; 35(1): 13 - 18. [Abstract] [Full Text] [PDF]

				B. Dahlof, R. B. Devereux, S. Julius, S. E. Kjeldsen, G. Beevers, U. de Faire, F. Fyhrquist, T. Hedner, H. Ibsen, K. Kristianson, et al. Characteristics of 9194 Patients With Left Ventricular Hypertrophy : The LIFE Study Hypertension, December 1, 1998; 32(6): 989 - 997. [Abstract] [Full Text] [PDF]

				P. M. Okin, M. J. Roman, R. B. Devereux, T. G. Pickering, J. S. Borer, and P. Kligfield Time-Voltage QRS Area of the 12-Lead Electrocardiogram : Detection of Left Ventricular Hypertrophy Hypertension, April 1, 1998; 31(4): 937 - 942. [Abstract] [Full Text] [PDF]

				S. G. Sheps and E. D. Frohlich Limited Echocardiography for Hypertensive Left Ventricular Hypertrophy Hypertension, February 1, 1997; 29(2): 560 - 563. [Full Text]

				P. M. Okin, M. J. Roman, R. B. Devereux, and P. Kligfield Association of Carotid Atherosclerosis With Electrocardiographic Myocardial Ischemia and Left Ventricular Hypertrophy Hypertension, July 1, 1996; 28(1): 3 - 7. [Abstract] [Full Text]

				P. M. Okin, M. J. Roman, R. B. Devereux, and P. Kligfield Time-Voltage Area of the QRS for the Identification of Left Ventricular Hypertrophy Hypertension, February 1, 1996; 27(2): 251 - 258. [Abstract] [Full Text]

				P. M. Okin, M. J. Roman, R. B. Devereux, and P. Kligfield Gender Differences and the Electrocardiogram in Left Ventricular Hypertrophy Hypertension, February 1, 1995; 25(2): 242 - 249. [Abstract] [Full Text]